NDC product
Nicardipine Hydrochloride
NDC 0517-0735 · American Regent, Inc.
Key facts
| Product NDC | 0517-0735 |
|---|---|
| Proprietary name | Nicardipine Hydrochloride |
| Nonproprietary name | nicardipine hydrochloride |
| Substances | NICARDIPINE HYDROCHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Labeler | American Regent, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA090534 |
| Pharmacologic classes | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC] and 1 more |
| Marketing start | May 8, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: